Boston Scientific Corporation (NYSE: BSX) announced the schedule of the Company's major events and sponsored research at the 31st Annual Scientific Sessions of the Heart Rhythm Society (HRS), May 12 - 15 in Denver. The scheduled clinical presentations will provide new insights for physicians who treat patients with implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds). Schedule of Events (All times are Mountain Time; all events take place in the Colorado Convention Center unless otherwise indicated.)
- 22nd Annual Michel Mirowski Sudden Cardiac Arrest Symposium and Award Presentation. The Company will sponsor the 22nd Annual Michel Mirowski Sudden Cardiac Arrest Symposium and Award Presentation on Wednesday, May 12, 7:00 - 10:00 p.m. in the Centennial Ballroom of the Hyatt Regency Denver Hotel. The event will feature a keynote address by Richard Page, M.D., followed by the award ceremony honoring this year's Mirowski Award recipient Jose Jalife, M.D., Ph.D. Hugh Calkins, M.D., will then lead an esteemed faculty, including Ronald Berger, M.D., Ph.D., Meleze Hocini, M.D., and Dr. Jalife, in a discussion of the latest clinical data on predictors of sudden cardiac death.
Sessions related to Boston Scientific's landmark MADIT-CRT heart failure trial:
MADIT-CRT is the world's largest randomized study of New York Heart Association (NYHA) Class I and II patients, with more than 1,800 patients enrolled at 110 centers worldwide. Results of the MADIT-CRT trial were published in the October 2009 issue of the New England Journal of Medicine. Boston Scientific currently has an application under review with the U.S. Food and Drug Administration (FDA) for the expansion of its CRT-D indication to include high-risk New York Heart Association Class I and II patients with left bundle branch block (1).
- Late-breaking clinical trials: Left Ventricular Lead Position and Clinical Outcome: Findings from MADIT-CRT. Jagmeet Singh, M.D., will present his findings on Thursday, May 13, 8:30 - 8:45 a.m. in Four Seasons Ballroom 3 - 4.
- CRT-D Effectiveness by QRS Duration and Morphology in MADIT-CRT Patients. This abstract session will be presented on Thursday, May 13, 1:45 - 2:00 p.m. in Korbel Ballroom 3A.
- Predictors of Response to Preventive CRT in MADIT-CRT. This abstract session will be presented on Thursday, May 13, 2:00 - 2:15 p.m. in Korbel Ballroom 3A.
- One Train of Antitachycardia Pacing is Successful for Fast Ventricular Tachycardia in Patients with Conduction Abnormalities and Left Ventricular Dysfunction: Results from the MADIT-CRT study. This poster session will be featured on Friday, May 14, at 9:00 a.m. in the Exhibit Hall.
(1) High-risk is defined as QRS width >130 milliseconds, Left Ventricular Ejection Fraction < 30 percent and left bundle branch block.
Sessions related to Boston Scientific's ALTITUDE clinical science program:
The ALTITUDE clinical science program analyzes comprehensive data from the LATITUDE® Patient Management system. Boston Scientific has enrolled more than 160,000 patients on the LATITUDE system since its introduction in 2006. The ALTITUDE program enhances understanding of device therapy, outcomes and disease progression. The LATITUDE system enables physicians to schedule remote follow-ups of implantable cardiac device patients to monitor specific device information and heart health status. The system can also detect clinical events between scheduled visits and send relevant data directly to physicians. This in-home monitoring offers convenience and peace of mind for patients.
- Real World ICD/CRT-D Patient Survival: Do Women Fare Better than Men? Gender Comparison in the ALTITUDE Study. This featured poster session will be presented during a reception on Wednesday, May 12, 5:45 - 7:00 p.m. in the Lower D Lobby.
- Comparison of Tachycardia Detection Programming and Shock Incidence in the ALTITUDE Study. This poster session will be featured on Thursday, May 13, at 9:00 a.m. in the Exhibit Hall. F. Roosevelt Gilliam, M.D., will also present the study data in Boston Scientific's booth on Thursday, May 13, at 3:30 p.m. and Friday, May 14, at 9:30 a.m.
- Noise and Oversensing-Related Inappropriate ICD Shocks Diagnosed with Remote Monitoring: The ALTITUDE EGM Study. This abstract session will be presented on Thursday, May 13, 2:15 - 2:30 p.m. in Room 402.
No comments:
Post a Comment